102 research outputs found

    Estudio comparativo de la función del congresista en la aprobación de leyes con respecto a la experiencia congresal, periodo 2017-2018

    Get PDF
    El objetivo de esta investigación fue, realizar el estudio comparativo de la Función del Congresista en la aprobación de Leyes con respecto a la Experiencia Congresal, periodo 2017-2018. Comprender que es lo estaba fallando en los congresistas en la aprobación de leyes es sumamente fundamental por lo que se debe estudiar indicadores estadísticos. El enfoque de esta investigación fue cuantitativa, descriptiva de diseño no experimental, la muestra de 124 congresistas y el instrumento empleado fue la data congresal. Los resultados fueron en la Producción de leyes 2017 – 2018, 111 leyes aprobadas en el 2017, mucho menos leyes que en el 2018, de 297 leyes. Asimismo, el género femenino se desempeñó mejor con 35 congresistas aprobó 153 leyes. Por otra parte, los 29 congresistas con menor o igual a 40 años aprobaron 120 leyes. Cabe destacar que el distrito electoral con más leyes aprobadas por los congresistas fue Lima con 137 leyes, debido a que presenta mayor cantidad de 40 congresistas, mientras que por partido político fue Fuerza Popular con 243 leyes aprobadas, también presenta mayor cantidad de congresistas. Por otro lado, los congresistas sin experiencia parlamentaria aprobaron más leyes que con experiencia, 288 leyes. Por consiguiente, los congresistas con estudios fue ampliamente superior con 388 leyes aprobadas. Concluyó que el año 2018 aprobaron más leyes que el 2017, que el género femenino a pesar de ser menor cantidad en el congreso fueron las que aprobaron más en promedio, que los congresistas con edad menor se desempeñaron mejor, Lima tuvo mayor número de congresistas y por ende mayor cantidad de leyes, el partido político más productivo fue Fuerza Popular, los representantes sin experiencia parlamentaria aprobaron más leyes y finalmente, los congresistas para tener una eficiente función en la aprobación de leyes deben estar preparado en formación profesional

    Organic batteries based on just redox polymers

    Get PDF
    [EN]Redox-active polymers have gained interest as environmentally friendly alternative to inorganic materials in applications such as electrodes in lithium-ion batteries. All-polymer batteries were first disregarded with respect to other technologies due to their lower energy densities. However, the inherent benefits of redox polymers such as processability, flexibility, recyclability, high-rate performance and the perspective to prepare batteries from renewable resources has re-ignited interest in recent years. This review article aims to provide a comprehensive overview on the state of the art of batteries in which the active material is a redox polymer; including "static" all-polymer batteries and polymer-air batteries but also "flowing" systems such as polymer based redox-flow batteries (pRFB). First, a succinct overview of the recent developments of redox polymers will be given, summarizing the historic trends and developments. Second, an exhaustive discussion of the various battery prototypes will be provided, considering all steps in the development of organic batteries just based in redox polymers. Finally, future perspectives on all-polymer batteries will be discussed, summarizing the major challenges that are still to be overcome to unlock their commercial implementation.Authors thank POLYSTORAGE ETN project, this project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skodowska-Curie grant agreement No 860403. RM and NP thank the Spanish MCI through the SUSBAT project (Ref. RTI2018-101049-B-I0 0) and Juan de la Cierva fellowship [FJC2018-037781-I] (MCI-AEI/FEDER, UE) . NC would like to thank the University of the Basque Country forfunding through a specialization of research staff fellowship (ES-PDOC 19/99) . NG acknowledges the funding from the European Union's Horizon 2020 framework programme under the Marie Skodowska-Curie Agreement No. 101028682

    Evaluation of NAB2-STAT6 Fusion Variants and Other Molecular Alterations as Prognostic Biomarkers in a Case Series of 83 Solitary Fibrous Tumors

    Get PDF
    Risk stratification of solitary fibrous tumor (SFT) patients based on clinicopathological features has limited efficacy, especially in predicting late relapse or metastasis. The hallmark alteration of SFT is the gene fusion NAB2-STAT6, whose prognostic value remains controversial. As biological knowledge of this entity has increased in recent years, new molecular alterations have emerged that could be helpful to refine current risk models. Here, we evaluated NAB2-STAT6 fusion variants and other molecular alterations in a series of 83 SFTs that are enriched in progressing cases. Gene fusion variants were identified by targeted RNA-seq in the whole series, whereas TERT promoter (pTERT) mutations were inspected by Sanger sequencing in a subset of 18 cases. Immunohistochemical assays were performed to assess BCOR and NTRK expression as well as P53 mutation status in 45, 44, and 44 cases, respectively. While confirming the associations of gene fusion variants with clinicopathological parameters, our results do not prove their prognostic value. Pan-TRK immunoexpresion correlated with recurrence/progression, P53 staining associated with higher mitotic counts, and pTERT mutations were enriched in cases with fatal outcome. An intriguing correlation was found for BCOR protein expression with gene fusion variants, size, and tumor location

    Aging Effect of Catechol Redox Polymer Nanoparticles for Hybrid Supercapacitors

    Get PDF
    [EN] Redox-polymer nanoparticles are a promising solution to avoid the detrimental dissolution of organic electrode materials while showing discrete redox processes. In this work, catechol-based redox-active polymer nanoparticles (cRPNs) were synthesized through one-step emulsion polymerization with a tunable size from 25 to 150 nm. The fresh cRPNs were characterized and showed a reversible redox process centered at 0.50 V (vs. Ag/AgCl) in 1 M H2SO4. Unexpectedly, the cRPN latex aged after days passing from white to pink. This aging resulted in a shift of its redox potential toward higher values, which could be associated to autoxidation of the catechol groups and subsequent crosslinking of NPs due to catechol dimer formation. Finally, we compared the performance of fresh and aged cRPNs in a hybrid supercapacitor device, proving how the aging effect had some benefits such as an increase in the voltage output, specific capacitance, cyclability and Coulombic efficiencies of the device.The authors thank for technical and human support provided by IZO-SGI SGIker of UPV/EHU. Technical and human support provided by IZO-SGI, SGIker (UPV/EHU, MICINN, GV/EJ, ERDF and ESF) is gratefully acknowledged for assistance and generous allocation of computational resources. The authors would like to thank the European Commission for financial support through funding from the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No 823989. N.P. appreciates Spanish MINECO for the Juan de la Cierva-formation fellowship (FJC2018-037781-I). R.M. thanks the Spanish Ministry of Science, Innovation and Universities through the SUSBAT project (Ref.RTI2018-101049-B-I00) (MINECO/FEDER, UE) for financial support

    Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients

    Get PDF
    Wilms tumour (WT) is the most common renal tumour in children. Most WT patients respond to chemotherapy, but subsets of tumours develop resistance to chemotherapeutic agents, which is a major obstacle in their successful treatment. Multidrug resistance transporters play a crucial role in the development of resistance in cancer due to the efflux of anticancer agents out of cells. The aim of this study was to explore several human multidrug resistance transporters in 46 WT and 40 nonneoplastic control tissues (normal kidney) from patients selected after chemotherapy treatment SIOP 93–01, SIOP 2001. Our data showed that the majority of the studied multidrug resistance transporters were downregulated or unchanged between tumours and control tissues. However, BCRP1, MDR3 and MRP1 were upregulated in tumours versus control tissues. MDR3 and MRP1 overexpression correlated with highrisk tumours (SIOP classification) (p = 0.0022 and p < 0.0001, respectively) and the time of disease-free survival was significantly shorter in patients with high transcript levels of MDR3 (p = 0.0359). MDR3 and MRP1 play a role in drug resistance in WT treatment, probably by alteration of an unspecific drug excretion system. Besides, within the blastemal subtype, we observed patients with low MDR3 expression were significantly associated with a better outcome than patients with high MDR3 expression. We could define two types of blastemal WT associated with different disease outcomes, enabling the stratification of blastemal WT patients based on the expression levels of the multidrug resistance transporter MDR3.Ministerio de Economía y Competitividad PI1401466, RD06/0020/0059, PI1100018, CD06/00001Red Tematica de Investigacion Cooperativa en Cancer RD12/0036/0017Unión Europea FP7-HEALTH- 2011-two-stage, Project ID 278742 EUROSARCInstituto de Salud Carlos III FIS PI13/0228

    Hippo pathway effectors YAP1/TAZ induce an EWS–FLI1‐opposing gene signature and associate with disease progression in Ewing sarcoma

    Get PDF
    YAP1 and TAZ (WWTR1) oncoproteins are the final transducers of the Hippo tumor suppressor pathway. Deregulation of the pathway leads to YAP1/TAZ activation fostering tumorigenesis in multiple malignant tumor types, including sarcoma. However, oncogenic mutations within the core components of the Hippo pathway are uncommon. Ewing sarcoma (EwS), a pediatric cancer with low mutation rate, is characterized by a canonical fusion involving the gene EWSR1 and FLI1 as the most common partner. The fusion protein is a potent driver of oncogenesis, but secondary alterations are scarce, and little is known about other biological factors that determine the risk of relapse or progression. We have observed YAP1/TAZ expression and transcriptional activity in EwS cell lines. Analyses of 55 primary human EwS samples revealed that high YAP1/TAZ expression was associated with progression of the disease and predicted poorer outcome. We did not observe recurrent SNV or copy number gains/losses in Hippo pathway‐related loci. However, differential CpG methylation of the RASSF1 locus (a regulator of the Hippo pathway) was observed in EwS cell lines compared with mesenchymal stem cells, the putative cell of origin of EwS. Hypermethylation of RASSF1 correlated with the transcriptional silencing of the tumor suppressor isoform RASFF1A, and transcriptional activation of the pro‐tumorigenic isoform RASSF1C, which promotes YAP1/TAZ activation. Knockdown of YAP1/TAZ decreased proliferation and invasion abilities of EwS cells and revealed that YAP1/TAZ transcription activity is inversely correlated with the EWS–FLI1 transcriptional signature. This transcriptional antagonism could be explained partly by EWS–FLI1‐mediated transcriptional repression of TAZ. Thus, YAP1/TAZ may override the transcriptional program induced by the fusion protein, contributing to the phenotypic plasticity determined by dynamic fluctuation of the fusion protein, a recently proposed model for disease dissemination in EwS

    Polyimides as Promising Cathodes for Metal-Organic Batteries: A Comparison between Divalent (Ca2+, Mg2+) and Monovalent (Li+, Na+) Cations

    Get PDF
    Ca- and Mg-based batteries represent a more sustainable alternative to Li-ion batteries. However, multivalent cation technologies suffer from poor cation mass transport. In addition, the development of positive electrodes enabling reversible charge storage currently represents one of the major challenges. Organic positive electrodes, in addition to being the most sustainable and potentially low-cost candidates, compared with their inorganic counterparts, currently present the best electrochemical performances in Ca and Mg cells. Unfortunately, organic positive electrodes suffer from relatively low capacity retention upon cycling, the origin of which is not yet fully understood. Here, 1,4,5,8-naphthalenetetracarboxylic dianhydride-derived polyimide was tested in Li, Na, Mg, and Ca cells for the sake of comparison in terms of redox potential, gravimetric capacities, capacity retention, and rate capability. The redox mechanisms were also investigated by means of operando IR experiments, and a parameter affecting most figures of merit has been identified: the presence of contact ion-pairs in the electrolyte.Funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement no. 715087) is gratefully acknowledged. ICMAB-CSIC members are grateful for funding through PTI+ TRANSENER+: “Alta Tecnología clave en la transición en el ciclo energético”, part of the CSIC program for the Spanish Recovery, Transformation and Resilience Plan funded by the Recovery and Resilience Facility of the European Union, established by the Regulation (EU) 2020/2094 and thank the Spanish Agencia Estatal de Investigación Severo Ochoa Programme for Centres of Excellence in R&D (CEX2019-000917-S).With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000917-S).Peer reviewe

    The SysteMHC Atlas project.

    Get PDF
    Mass spectrometry (MS)-based immunopeptidomics investigates the repertoire of peptides presented at the cell surface by major histocompatibility complex (MHC) molecules. The broad clinical relevance of MHC-associated peptides, e.g. in precision medicine, provides a strong rationale for the large-scale generation of immunopeptidomic datasets and recent developments in MS-based peptide analysis technologies now support the generation of the required data. Importantly, the availability of diverse immunopeptidomic datasets has resulted in an increasing need to standardize, store and exchange this type of data to enable better collaborations among researchers, to advance the field more efficiently and to establish quality measures required for the meaningful comparison of datasets. Here we present the SysteMHC Atlas (https://systemhcatlas.org), a public database that aims at collecting, organizing, sharing, visualizing and exploring immunopeptidomic data generated by MS. The Atlas includes raw mass spectrometer output files collected from several laboratories around the globe, a catalog of context-specific datasets of MHC class I and class II peptides, standardized MHC allele-specific peptide spectral libraries consisting of consensus spectra calculated from repeat measurements of the same peptide sequence, and links to other proteomics and immunology databases. The SysteMHC Atlas project was created and will be further expanded using a uniform and open computational pipeline that controls the quality of peptide identifications and peptide annotations. Thus, the SysteMHC Atlas disseminates quality controlled immunopeptidomic information to the public domain and serves as a community resource toward the generation of a high-quality comprehensive map of the human immunopeptidome and the support of consistent measurement of immunopeptidomic sample cohorts

    Minimal information for studies of extracellular vesicles 2018 (MISEV2018):a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines

    Get PDF
    The last decade has seen a sharp increase in the number of scientific publications describing physiological and pathological functions of extracellular vesicles (EVs), a collective term covering various subtypes of cell-released, membranous structures, called exosomes, microvesicles, microparticles, ectosomes, oncosomes, apoptotic bodies, and many other names. However, specific issues arise when working with these entities, whose size and amount often make them difficult to obtain as relatively pure preparations, and to characterize properly. The International Society for Extracellular Vesicles (ISEV) proposed Minimal Information for Studies of Extracellular Vesicles (“MISEV”) guidelines for the field in 2014. We now update these “MISEV2014” guidelines based on evolution of the collective knowledge in the last four years. An important point to consider is that ascribing a specific function to EVs in general, or to subtypes of EVs, requires reporting of specific information beyond mere description of function in a crude, potentially contaminated, and heterogeneous preparation. For example, claims that exosomes are endowed with exquisite and specific activities remain difficult to support experimentally, given our still limited knowledge of their specific molecular machineries of biogenesis and release, as compared with other biophysically similar EVs. The MISEV2018 guidelines include tables and outlines of suggested protocols and steps to follow to document specific EV-associated functional activities. Finally, a checklist is provided with summaries of key points

    Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Get PDF
    Extracellular vesicles (EVs), through their complex cargo, can reflect the state of their cell of origin and change the functions and phenotypes of other cells. These features indicate strong biomarker and therapeutic potential and have generated broad interest, as evidenced by the steady year-on-year increase in the numbers of scientific publications about EVs. Important advances have been made in EV metrology and in understanding and applying EV biology. However, hurdles remain to realising the potential of EVs in domains ranging from basic biology to clinical applications due to challenges in EV nomenclature, separation from non-vesicular extracellular particles, characterisation and functional studies. To address the challenges and opportunities in this rapidly evolving field, the International Society for Extracellular Vesicles (ISEV) updates its 'Minimal Information for Studies of Extracellular Vesicles', which was first published in 2014 and then in 2018 as MISEV2014 and MISEV2018, respectively. The goal of the current document, MISEV2023, is to provide researchers with an updated snapshot of available approaches and their advantages and limitations for production, separation and characterisation of EVs from multiple sources, including cell culture, body fluids and solid tissues. In addition to presenting the latest state of the art in basic principles of EV research, this document also covers advanced techniques and approaches that are currently expanding the boundaries of the field. MISEV2023 also includes new sections on EV release and uptake and a brief discussion of in vivo approaches to study EVs. Compiling feedback from ISEV expert task forces and more than 1000 researchers, this document conveys the current state of EV research to facilitate robust scientific discoveries and move the field forward even more rapidly
    corecore